• RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy and

  2026-07-08

  RapaLink-1 sets a new benchmark in mTOR pathway research by enabling robust, reversible induction of cellular dormancy and overcoming resistance in cancer models. This guide details practical workflows, protocol enhancements, and troubleshooting strategies, making it essential reading for scientists exploring embryonic development or advanced oncology applications.

• Trilaurin-Based Solid Lipid Microparticles for Oral Peptide

  2026-07-07

  This study demonstrates that trilaurin (glycerol tridodecanoate) solid lipid microparticles (SLM) protect desmopressin from proteolytic degradation during simulated gastrointestinal digestion, supporting its value as a lipid excipient for oral delivery of peptide drugs. The findings clarify how trilaurin digestion modulates drug release and enzyme protection, with implications for designing advanced oral peptide and protein drug formulations.

• Tubeimoside I as a Selective Senolytic Targeting ATP1A1 in A

  2026-07-07

  The referenced study establishes Tubeimoside I as a selective senolytic agent that targets the sodium/potassium-ATPase alpha 1 subunit (ATP1A1), efficiently eliminating senescent cells and alleviating age-associated tissue damage in vivo. This work introduces a novel mechanistic approach to senolysis via ion homeostasis disruption, with broad implications for aging and degenerative disease research.

• Deracoxib: Selective COX-2 Inhibitor for Advanced Cancer and

  2026-07-06

  Deracoxib is redefining selective COX-2 inhibition for both inflammation and tumor biology studies, enabling precise dissection of prostaglandin and apoptosis pathways with quantitative reliability. This article delivers actionable protocols, advanced use-cases, and troubleshooting strategies to maximize the impact of Deracoxib in translational veterinary research.

• Piezo1 Senses Matrix Stiffness to Regulate DRG Axon Regenera

  2026-07-06

  This study reveals that the mechanosensitive ion channel Piezo1 functions as a key sensor of substrate stiffness in dorsal root ganglion (DRG) neurons, orchestrating axon regrowth via downstream cytoskeletal signaling. The findings underscore substrate mechanical properties as actionable targets for nerve repair strategies and clarify the molecular cascade coupling environmental stiffness to cytoskeletal remodeling.

• Cyclic Pifithrin-α Hydrobromide: Advanced p53 Inhibition Wor

  2026-07-05

  Cyclic Pifithrin-α hydrobromide empowers researchers to precisely modulate the p53 signaling pathway, enabling innovative protocols for apoptosis inhibition and radioprotection. This article delivers actionable workflows and troubleshooting insights, bridging the latest mechanistic advances to reproducible experimental outcomes.

• Jasplakinolide: Precision Actin Polymerization Inducer in Re

  2026-07-04

  Jasplakinolide stands apart as an actin polymerization inducer with nanomolar potency, enabling high-resolution control over cytoskeletal dynamics in live-cell and translational assays. Discover how APExBIO's Jasplakinolide streamlines advanced cytoskeletal workflows, supports antifungal and antiproliferative research, and overcomes common experimental pitfalls with robust protocol insights.

• Berberrubine Modulates Metabolism and Microbiota in NAFLD Mo

  2026-07-03

  This study demonstrates that berberrubine, a primary metabolite of berberine, effectively ameliorates non-alcoholic fatty liver disease (NAFLD) by modulating glucose and lipid metabolism and restoring gut microbiota composition in high-fat diet mouse models. The findings highlight berberrubine’s molecular mechanisms of action and its potential as a therapeutic candidate for metabolic liver diseases.

• Distinct Apoptotic Pathways in BMECs Triggered by Candida kr

  2026-07-03

  Miao et al. (2023) demonstrated that the yeast and hypha phases of Candida krusei induce apoptosis in bovine mammary epithelial cells (BMECs) via fundamentally different signaling pathways. This work clarifies the molecular underpinnings of fungal mastitis and provides a basis for pathway-specific interventions in dairy cow health.

• Taltirelin Enhances Motor Function in Hemi-Parkinsonian Rats

  2026-07-02

  The reference study demonstrates that Taltirelin, a long-acting TRH analog, improves motor function in a hemi-Parkinson's disease rat model without inducing dyskinesia. These findings highlight a sustained, gentle modulation of dopamine release with mechanistic specificity, offering new translational avenues for neurodegenerative disease research.

• ML-7 Hydrochloride in Ischemia/Reperfusion: Mechanistic Insi

  2026-07-02

  Explore the mechanistic role of ML-7 hydrochloride as a myosin light chain kinase inhibitor in ischemia/reperfusion injury research. This article uniquely connects molecular mechanisms to assay design, offering actionable insights not found in generic overviews.

• WP1066, JAK2/STAT3 Inhibitor: Applied Protocols in Cancer &

  2026-07-01

  WP1066, a potent cell-permeable JAK2/STAT3 inhibitor from APExBIO, stands apart for its dual action in cancer and regenerative medicine workflows. This guide details evidence-based protocols, troubleshooting strategies, and the latest cross-domain innovations, ensuring researchers maximize the compound’s full experimental potential.

• Jasplakinolide: Precision Actin Polymerization Inducer for C

  2026-07-01

  Jasplakinolide stands apart as a powerful, membrane-permeable actin polymerization inducer, enabling advanced manipulation of cytoskeletal dynamics in cell biology and antifungal research. This guide demystifies workflow enhancements, troubleshooting, and protocol parameters to maximize reproducibility with APExBIO’s validated Jasplakinolide.

• Ethacridine Lactate Monohydrate: Precision Antisepsis for Ep

  2026-06-30

  Explore how Ethacridine lactate monohydrate, a high-purity antiseptic agent, optimizes microbial control in advanced epigenetic and differentiation assays. This article uncovers its mechanistic strengths and critical role in preserving assay integrity for super-enhancer and chromatin studies.

• Decoding Aneugenicity: Mechanistic Insights from Reference C

  2026-06-30

  The referenced study introduces a tiered assay to delineate the molecular mechanisms underlying chemical-induced aneugenicity, focusing on tubulin dynamics and mitotic kinase inhibition. Its robust machine learning approach enables reliable classification of aneugenic agents, offering practical implications for genotoxicity screening and drug safety evaluation.

764 records 12/51 page Previous Next First page 上5页 1112131415 下5页 Last page